Bharat Biotech gets permission to manufacture Covaxin for sale

Mid-Day

03 Jan 2021 0 shares 1 views

Bharat Biotech gets permission to manufacture Covaxin for sale

Bharat Biotech gets permission to manufacture Covaxin for sale

Mid-Day

Published 03 Jan 2021

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.

"The Central Licensing Authority has granted permission to Bharat Biotech International Ltd...

You might like

Related news coverage

Bharat Biotech makes big announcement, reveals who should avoid COVID-19 vaccine

Zee News 19 Jan 2021

Covaxin is a vaccine with approval for restricted use in emergency situations that may prevent COVID-19. The Central Licensing..

Enough stock of COVID-19 vaccine for first phase of vaccination drive: Centre
Mid-Day 04 Jan 2021
Shashi Tharoor critcises Centre for giving nod to Bharat Biotech vaccine without phase 3 trials
Mid-Day 04 Jan 2021
COVID-19: India's daily numbers dip to 16,504
Mid-Day 04 Jan 2021
Covaxin generated excellent safety data, says Bharat Biotech
Mid-Day 04 Jan 2021

Advertisement

More coverage

Zydus Cadila gets nod for phase 3 trials of its COVID-19 vaccine candidate

Mid-Day 03 Jan 2021

The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate..

Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to Covaxin
DNA 03 Jan 2021
A decisive turning point: PM Narendra Modi lauds scientists over COVID-19 vaccine approval
Mid-Day 03 Jan 2021
Congress leaders raise concern over grant of permission for restricted use of COVID-19 vaccine
Hindu 03 Jan 2021
India approves Covishield, Covaxin vaccines for emergency use
Mid-Day 03 Jan 2021